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Abstract
Manipulations of lethally-irradiated animals, such as for administration of pharmaceuticals, blood 
sampling, or other laboratory procedures, have the potential to induce stress effects that may 
negatively affect morbidity and mortality. To investigate this in a murine model of the 
hematopoietic acute radiation syndrome, 20 individual survival efficacy studies were grouped 
based on the severity of the administration (Admn) schedules of their medical countermeasure 
(MCM) into Admn 1 (no injections), Admn 2 (one to three injections), or Admn 3 (29 injections 
or six to nine oral gavages). Radiation doses ranged from LD30/30 to LD95/30. Thirty-day 
survival of vehicle controls in each group was used to construct radiation dose lethality response 
relationship (DRR) probit plots, which were compared statistically to the original DRR from 
which all LDXX/30 for the studies were obtained. The slope of the Admn 3 probit was found to be 
significantly steeper (5.190) than that of the original DRR (2.842) or Admn 2 (2.009), which were 
not significantly different. The LD50/30 for Admn 3 (8.43 Gy) was less than that of the original 
DRR (8.53 Gy, p<0.050), whereas the LD50/30 of other groups were similar. Kaplan-Meier 
survival curves showed significantly worse survival of Admn 3 mice compared to the three other 
groups (p=0.007). Taken together, these results show that stressful administration schedules of 
MCM can negatively impact survival, and that dosing regimens should be considered when 
constructing DRR to use in survival studies.
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INTRODUCTION
The growing threat of terrorist use of radiation and radiation accidents at nuclear power 
facilities highlights the need for medical countermeasures (MCM) against radiation, and 
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appropriate animal models for testing such MCM. Over the past 10 years, the authors have 
developed and refined a total body irradiation (TBI) mouse model of the hematopoietic 
acute radiation syndrome (H-ARS) for efficacy testing of candidate MCM against radiation 
(Plett et al. 2012). This base H-ARS model, developed in 12 week old C57BL/6 mice, has 
been used extensively to a) test survival efficacy of more than 50 candidate MCM from the 
government or private industry in more than 150 efficacy screening assays, b) optimize the 
MCM dose and/or administration schedule of more than 20 MCM in more than 75 assays c) 
examine polypharmacy of more than 10 different MCM combinations, d) perform Good 
Laboratory Practices (GLP)-compliant survival studies, and d) perform Pharmacokinetic/
Pharmacodynamic PK/PD studies (Shakhov et al. 2012, Hoggatt et al. 2013, Chua et al. 
2014, Garrett et al. 2014, Plett et al. 2014). These data validate this H-ARS mouse model as 
a suitable model for efficacy testing of potential MCM and for qualification as a Drug 
Development Tool (DDT) by the FDA / Center for Drug Evaluation and Research (CDER).
The stability of the radiation Dose lethality Response Relationship (DRR) of the H-ARS 
model is essential for confidence in using the model for efficacy testing of candidate MCM. 
The DRR was established by irradiating mice at 6 different radiation doses ranging from 775 
to 900 cGy, which would result in 0 to 100% lethality. These data were then used to 
establish the range of lethal doses to be utilized in the subsequent studies. Stability of the 
DRR is assessed by monitoring “drift” in the expected survival of control groups. For 
example, if mice are exposed the LD50/30 (i.e., the lethal dose for 50% of the population by 
day 30), it is reasonable to expect survival in the control vehicle-treated group to be 50% ± 
20% (i.e., 40% to 60% survival). If survival exceeds ±20%, evaluation of the efficacy of the 
MCM can be difficult, especially if survival is higher than expected as this situation leaves 
little “room” for the candidate MCM to exhibit efficacy. Stability of the murine H-ARS 
DRR is sensitive to many factors, demanding extensive characterization of the model and 
any variables that can lead to drift in the expected survival of controls. Such variables 
include chronoradiosensitivity (daily, weekly, annual), support (antibiotics, wet feed), 
frequency of blood sampling, MCM dosing (volume, frequency, route), stress effects, 
caretakers (gender, experience, familiarity) characteristics of mice (strain, age, gender, 
weight, vendor, barrier, room), treatment of the mice (acclimation period, identification 
method, housing, vent rack, barrier cages, single or group housing), husbandry (nutritional 
status of food, bedding, enrichment, water pH, temperature, humidity, air changes, light:dark 
cycles), irradiation [source, dose rate, irradiation apparatus, geometry (partial body shielding 
vs. total body irradiation)], anesthesia, cage effects, water consumption post-irradiation, and 
euthanasia criteria (Plett et al. 2012). All these parameters are tightly controlled in the 
authors’ H-ARS model.
Another contributor to instability in the DRR is the use of inbred mice. While genetic 
uniformity and consistency make inbred mouse strains popular for medical research, DRR 
constructed with inbred strains are characteristically steep. The 95% confidence intervals 
(CI) around the calculated LDXX/30 in such DRR are considerably larger than CI of DRR 
constructed with genetically diverse animals, leading to a relatively large window of 
possible survival outcomes at a given LDXX/30. This observation has been previously 
acknowledged by Cerveny et al (Cerveny et al. 1989), where he notes: “the more inbred and 
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homogenous the population, the steeper the slope of the lethality curve”. Others have made 
similar statements: “it seems possible to conclude that the doses giving between 90%-95% 
mortality in most animal experiments are about twice those giving 5%-10% mortality” 
(Baverstock and Ash 1983). The authors have previously reported the slope of the DRR in 
their H-ARS model in C57BL/6 mice to be 2.56, whereas the slope of the DRR in the H-
ARS model generated with the genetically diverse non-human primates H-ARS model is 
1.13 (Farese et al. 2012), illustrating the steepness of DRR of inbred animals.
The authors have previously documented that lethally irradiated mice are sensitive to 
handling and manipulation post-exposure, such that excessive handling can lead to increased 
lethality (Plett et al. 2012). Thirty-day survival in mice that were bled every 5th day post-
LD90 for CBC analyses (~30uL per mouse via tail snips in mice immobilized within a 
plexiglass mouse restrainer) was significantly decreased compared to non-bled mice (3.2% 
versus 12.2%, p=0.008), as was mean and overall survival time (p≤0.031) (Plett et al. 2012). 
In addition, morbidity occurred earlier and was more prevalent in bled mice compared to 
non-bled (Plett et al. 2012). There appear to be two possible causes for the increased 
morbidity and mortality in bled mice: 1) the small amount of blood loss was sufficient to 
negatively affect their health in their weakened post-irradiation state, or 2) the added 
handling and manipulation of the mice during the blood draw negatively affected health in 
their weakened state. To fully understand the cause of the increased morbidity and mortality 
observed in bled mice, experiments in which control “un-bled” are similarly handled as bled 
mice would need to be performed. Regardless, these data show that lethally-irradiated mice 
are sensitive to stress effects that affect survival, and likely cannot undergo the same types 
or extent of manipulation in their weakened post-irradiation state that larger animals 
apparently can withstand, without impacting survival.
In addition to stress effects due to frequent blood sampling, the authors have also observed 
increased mortality in mice subjected to stressful MCM administration schedules that entail 
multiple daily injections or intrusive procedures such as multiple oral gavages. In such cases 
the LDXX/30 appears to be most negatively affected at higher radiation doses (≥ LD70/30) 
compared to lower radiation doses (i.e., LD30/30). Due to study-to-study drift in the DRR 
from such factors, 2 to 3 different doses of radiation (i.e., LD50/30, LD70/30 and/or 
LD90/30) are used in every efficacy screen (Plett et al. 2012, Chua et al. 2014, Plett et al. 
2014).
To better define the DRR and effects that excessive handling and / or manipulation of the 
mice can have on the DRR, as well as to investigate the stability of the DRR over time, the 
authors examined drift in the DRR over a 2.7 year period in 20 independent studies 
(n=15-103 mice per group). To this end, new DRR probit curves were constructed using 
mice from “control, vehicle-treated” groups in MCM efficacy screening studies. All control 
group mice were administered vehicle using the same administration schedule as that of the 
candidate MCM. While some administration schedules consisted of relatively few doses and 
simple routes of administration [i.e., 1-2 subcutaneous (SQ) injections], others were more 
stressful, requiring up to 29 SQ injections or multiple oral gavages. Experiments were thus 
categorized based on the “severity” of their administration schedules, and new DRR probit 
curves were generated that reflected relatively “light” administration schedules and those 
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that were more “stressful”. The new DRR were then compared statistically to the original 
DRR from which the LDXX/30 values for all the screening studies were obtained. The 
original DRR was generated in March 2012, and all MCM screening studies used in this 
analysis (n=20 studies) were performed in the subsequent 2.7 years.
MATERIALS AND METHODS
Mice
Specific pathogen free C57BL/6 mice (50/50 male/female; Jackson Laboratory, Bar Harbor, 
Maine) were received at 10 weeks of age, an age analogous to a “young adult” human. All 
studies are performed on mice of the same age to avoid age-related changes in 
radiosensitivity (Grahn and Hamilton 1957, Grahn 1958, Yuhas and Storer 1967, Casarett 
1968). Weights ranged from 16.0-21.6gm in females and 19.6-28.2gm in males. Mice were 
uniquely identified by ear punch and/or tail marks, and acclimatized for 2 weeks prior to 
irradiation. All studies were approved by the Indiana University School of Medicine 
Institutional Animal Care and Use Committee. Given the short duration of these survival 
studies, a sentinel mouse program, which analyzes mice every 3-4 months, was not used.
Husbandry
Up to 5 mice per cage were housed in microisolator cages on sterilized, certified direct 
contact bedding (Alpha Dri) and provided sterilized certified commercial extruded lab 
rodent chow (Harlan 2018SXC) ad libitum in cage hoppers and acidified water (pH 2.0-3.0) 
in sipper tube bottles. Autoclaved acidified water was provided on days 1-30 post-total body 
irradiation (TBI) in sipper tubes and on days 4-30 in wet feed in a petri dish set on the cage 
bottom. Animal rooms on a 12-hour light/dark cycle were maintained at 21±3°C with 
30-80% relative humidity and at least 10 air changes per hour of 100% conditioned fresh air. 
Mouse rooms were sanitized between studies.
Irradiation and dosimetry
Mice were placed in single chambers of a Plexiglas irradiation apparatus and were exposed 
to a single uniform total body dose of gamma radiation from a 137Cs radiation source at 0.97 
– 1.03 Gy min-1 (Mark 1 Irradiator, JL Shepherd, San Fernando, CA). These dose rates 
represent the decay in the cesium source over the 2.7yr period that the studies were 
performed. In-house dosimetry verified dose homogeneity in the exposure field of the mice 
was 0.0-4.3% of calculated central dose. For the DRR studies, mice were irradiated with 8 
doses (7.25, 7.50, 7.75, 8.00, 8.25, 8.50, 8.75, and 9.00 Gy), while for the Admn 1-3 studies 
mice were irradiated with doses between 8.53 and 9.27 Gy. The radiation source is 
stationary, while the irradiation apparatus is rotated during irradiation to ensure uniform 
exposure. To verify exposure doses, Landauer Inlight OSL nanodosimeters were placed in 
mouse phantoms and exposed along with the mice during every exposure. Nanodosimeters 
were read on a validated Landauer microStar reader calibrated with standard Dot dosimeters 
exposed with a NIST-traceable 137Cs source (Battelle Memorial Institute, WA). 
Reproducibility of individual dots was 3±1% with accuracy of 4±2%, well within the 10% 
industry standard for experimental radiation dosimetry. Dose output checks (using farmer-
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type ion chambers and a validated electrometer), and dose field uniformity checks by 
exposing film, are performed annually by an onsite medical physicist.
Health status monitoring
Irradiated mice were observed for morbidity and mortality twice daily by trained laboratory 
personnel and scored on a scale of zero to three for signs meeting the criteria for early 
euthanasia based on three parameters: the severity of hunched posture, squinted/closed eyes, 
and decreased activity, using our novel method as previously described (Plett et al. 2012). 
When the sum of the three scores equaled eight or nine, mice underwent humane euthanasia 
by CO2 inhalation followed by cervical dislocation. Using these criteria, approximately 50% 
of decedent mice undergo euthanasia, and approximately 50% are “found dead”. There were 
no differences in the distribution of mice undergoing euthanasia versus found dead in the 
current study (data not shown). Body weights, while useful for health status monitoring in 
some models, were not used in these studies to avoid any potentially negative effects on 
morbidity and mortality from the added stress of handling the weakened mice.
Study design
Twenty MCM screening studies or DRR stability studies performed over a period of 2.7 
years were separated into three groups based on the “severity” of the administration (Admn) 
regimen of the MCM (Table 1). Admn 1 studies (n=5) were designed to test the stability of 
the LD50/30 dose of radiation calculated in DRR study, and were repeated periodically to 
observe possible drift in the DRR curve. As such, there were no injections or administration 
of any MCM or vehicle in Admn 1 studies, and all experiments used the LD50/30, which 
was calculated to be 8.53 Gy from the original DRR. Admn 2 (n=11) comprised studies 
where the particular MCM or vehicle was administered in one to three SQ or intramuscular 
(IM) injections, beginning on day 1 post-irradiation and ending on day 2, 3, or 5 post-TBI. 
Mice in Admn 2 studies were exposed to the LD50/30, LD70/30 (8.72 Gy), LD90/30 (9.04 
Gy), or the LD96/30 (9.27 Gy). Admn 3 studies (n=4) comprised the most severe 
administration regimens, where the MCM / vehicles were administered via 29 consecutive 
SQ injections beginning on day 1 post-exposure, or six to nine every other day oral gavages 
beginning on day 1 post-exposure and continuing up to day 17 post-TBI. Mice in Admn 3 
studies were exposed to the LD30/30 (8.34 Gy), LD50/30, or the LD70/30. In all studies, 
each cage of mice was randomized by a study statistician to a radiation exposure dose and 
individual mice were randomized to treatment groups so that vehicle mice and MCM mice 
resided in the same cage. Volumes of vehicles used in these studies were 50 uL for IM and 
94 to 128 uL for SQ injections and oral gavages. Vehicle solutions consisted of: 20 mM 
Tris, pH 7.5, 200 mM NaCl, 10% glycerol; or 0.05% Tween-20; PlasmaLyte A solution; or 
10 mM sodium acetate, pH 4.8, 140 mM NaCl; or 10 mM sodium acetate, 5% sorbitol, 
0.003% polysorbate 20, pH 4.0; 160mmol/L sodium chloride solution (Normal saline; 0.9% 
NaCl, w/v); or 10 mM sodium phosphate, 4% mannitol, 1% sucrose pH 6.2; or Dextrose 5% 
in water (D5W), or 5% DMSO Polyethylene glycol (PEG)-200; or 10% EtOH Sesame oil: 
Cremophor RH40 (55:35 w/w); or 20 mM sodium phosphate monobasic; or 1% sucrose and 
4% D-mannitol in Water for Injection, pH 6.5±0.1. No data from the MCM groups are 
presented herein.
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Statistical analyses
Probit fits of mortality (DRR curves) were made using generalized linear models with a 
probit link, and comparisons of these fits were made using differences in deviance as a chi-
square statistic. LD50/30 comparisons were made using standard errors and covariances of 
slopes and intercepts of probit fits (Wald test). The log rank test was used to compare 
survival curves [Kaplan-Meier (KM) fits plotted]. Statistical comparisons and plots (figures) 
were made using the R software (http://cran.r-project.org/).
The KM survival curves for Admn 1, Admn 2, and Admn 3 used day 30 survival data for 
mice exposed to 8.53 Gy only (expected LD50/30). This radiation dose was not used in 
constructing the DRR, so the dose closest to 8.53 Gy (ie, 8.50 Gy) was used for the DRR 
KM survival curve. It was assumed that a 3 cGy offset would not contribute an appreciable 
difference in the survival curve. All survival data within these radiation doses were plotted, 
without regard to route of administration. Probit analyses used day 30 survival data across 
all radiation doses.
RESULTS
The original DRR was constructed with 164 mice randomized into 10 groups of 13 to 23 
mice/group. Each group was exposed to a different radiation dose ranging from 7.25 to 9.00 
Gy in increments of 0.25 Gy. Survival on day 30 was used to construct the DRR shown in 
Fig. 1, which defined the following LDXX/30 (±95% CI) doses of radiation: LD30/30 = 
8.34 (±10.81) Gy, LD50/30 = 8.53 (±10.63) Gy, LD70 = 8.72 (±13.68) Gy, LD90 = 9.04 
(±22.21) Gy, and LD96/30 = 9.27 (±30.54) Gy. These LDXX/30 were used in subsequent 
MCM screening assays, of which the control vehicle-treated groups were used herein to 
investigate the stability of the original DRR and the effect that handling and manipulation of 
the mice have on survival predicted from the original DRR.
Admn 1, which is comprised of mice exposed to the LD50/30 (8.53 Gy) but not injected 
with any vehicle, is shown as a single point on Fig. 1 since these mice were exposed to only 
one radiation dose. Analyses of slopes for the original DRR, Admn 2, and Admn 3 mice 
showed (Chi-square test) that these slopes were statistically different (p=0.0013). A 
comparison of the slopes of the original DRR and Admn 2 (2.842 (±0.699 95%CI) and 
2.009 (±0.836 95%CI), respectively) showed that they were not significantly different 
(p=0.120). In addition, there was no significant shift left or right of the Admn 2 probit 
compared to the original DRR (p=0.530). Thus, these two data sets are statistically 
indistinguishable and it can be concluded that the statistical difference in the overall 
comparison is due to the Admn 3 probit, which has a significantly steeper slope (5.190) 
compared those of the DRR and Admn 2 probits.
The LD50/30 value for the Admn 3 probit was found to be less than that of the original DRR 
probit (8.43 Gy versus 8.53 Gy, respectively, p<0.050, Table 2), illustrating that the stressful 
vehicle administration schedules of Admn 3 negatively impacted survival. The LD50/30 of 
the Admn 2 probit (8.48 Gy) was not statistically different than that of the DRR or of Admn 
3 (p>0.050, unadjusted comparisons).
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Of interest, lethality in mice exposed to the highest doses in Admn 3 (LD70/30, 8.72 Gy) 
was more disparate from the original DRR than mice exposed to the lowest doses (i.e., 
LD30/30, 8.34 Gy). In the LD70/30 groups, lethality was 29-43% higher than the expected 
LD70/30 (actual LDXX/30 = LD90/30 and LD100/30, Table 1), while actual lethality in the 
LD30/30 groups was LD30/30 and LD35/30. These data suggest that mice exposed to higher 
doses of radiation are more negatively affected by stressful administration regimens than 
mice exposed to lower doses.
The Kaplan-Meier (KM) survival curves shown in Fig. 2 used day 30 survival data for mice 
exposed to 8.53 Gy only (LD50/30; Admn 1, Admn 2, and Admn 3), or 8.50 Gy in the case 
of the DRR, since the DRR did not contain a group exposed to 8.53 Gy. A log rank test 
comparing all four KM curves indicated differences among the groups (p=0.007), whereas a 
log rank test comparing DRR, Admn 1, and Admn 2 indicated no differences (p=0.882), 
illustrating that the KM of Admn 3 mice was statistically different from the other three KM 
curves.
DISCUSSION
These data illustrate the sensitivity of the mouse radiation dose lethality response 
relationship (DRR) to handling and manipulation of mice during the acute phase of the 
radiation response. These data further show that mice exposed to higher doses of radiation 
(LD70/30) are more susceptible to stress effects than mice exposed to lower doses 
(LD30/30). It is noteworthy that the actual LDXX/30 in mice exposed to the LD90/30 or 
higher in the Admn 2 group was usually very close to the expected LDXX/30, supporting 
the notion that stressful administration schedules (rather than drift in the DRR curve) are 
responsible for the increased lethality in the high radiation dose groups. The incremental 
effect of stress at higher radiation doses could be due to the effects of ARS on other organ 
systems, such as the gastrointestinal system, thus increasing the sensitivity of the mice to 
handling stress and infections.
These results build upon the authors’ previously published data documenting increased 
lethality in mice undergoing periodic (every 5th day) blood sampling during the first 30 days 
post-radiation exposure (Plett et al. 2012). While it is unknown whether the increased 
lethality in the Plett 2012 paper was due to loss of blood or increased handling necessary 
during the blood draw, data in the current paper suggest that handling alone during vehicle 
administration can result in increased lethality, absent any blood sampling. It has been 
hypothesized by us (Plett et al. 2012) and others (Booth et al. 2012) that the extra fluid 
administered during vehicle administration may positively affect health and survival after 
radiation. Results presented herein show a significant shift to the left of the Admn 3 DRR 
compared to the other groups, suggesting that the stress of frequent handling over-shadowed 
any potential benefit of fluid support from the vehicle administrations. Further studies in 
similar models using similar radiation doses may be warranted to better understand the 
potential survival benefit of fluid administration balanced by the potential negative effects of 
repeated handling of the mice during fluid administration. Additionally, some Admn 2 
protocols (study numbers 6, 7, 9, 10, 11, 13, and 14) required bleeding mice by tail snips 
twice during the study, but not more than once every 14 days, which appeared to not affect 
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lethality in general. These results suggest that lethality is not negatively affected by 
intermittent handling of mice, such as blood sampling once every 14 days or dosing 3 times 
or fewer, and that care should be taken to limit the number of times that lethally-irradiated 
mice are handled during the acute phase.
Several measures can be taken to circumvent the demonstrated stress effects on lethality 
when repeat MCM administration is necessary for efficacy. Ideally, a complete DRR would 
be generated using groups of mice exposed to increasing doses of radiation and injected with 
vehicle using the same administration schedule required for the MCM. LDXX/30 values are 
then calculated from the DRR and radiation doses selected for the efficacy study. Absent 
construction of such a DRR, two or more doses of radiation would be selected for the 
efficacy study, taking care to select doses that may be lower than desired to allow for the 
possibility of increased lethality due to stress effects. Optimally, MCM can be engineered to 
require only a few injections, which has the added logistical benefit for ease of usage in the 
field.
Rigorous testing of new DRR curves is undertaken in the authors’ lab to ensure stability of 
LDXX/30 doses used in efficacy studies. Testing is carried out by exposing several groups 
of mice over time to the LD50/30 from the new DRR curve and documenting 30 day 
survival. These studies, comprising the five Admn 1 studies in the current paper with a total 
of 274 mice, gave an average LD of LD53/30, which is very close to the expected LD50/30. 
The range of actual LDXX/30 in individual studies was, however, LD39/30 to LD68/30, 
which exceeds the desirable ±20% variance. Drift in these studies is partly due to the use of 
inbred animals, which are inherently variable due to steep DRR curves compared to those 
generated in genetically diverse animals (Cerveny et al. 1989). To control for in-study drift 
as much as possible, 2 to 3 different doses of radiation (usually LD50/30, LD70/30 and/or 
LD90/30) are used in every efficacy study in the authors’ lab (Plett et al. 2012, Chua et al. 
2014, Plett et al. 2014). Also important is sufficient group size. When two doses of radiation 
are used in efficacy studies, 20 mice/group provides 80% power with a two-tailed 5% 
significance level assuming a 30% reduction in lethality in treated mice (Chua et al. 2012, 
Plett et al. 2012, Chua et al. 2014, Plett et al. 2014).
The question remains as to what aspect of excessive handling/manipulation of the mice 
increases lethality? While this remains unanswered, a few hypotheses can be entertained. It 
is well known that common laboratory procedures such as handling, blood collection, 
restraining, and, in particular, oral gavage induce measureable stress in mice and other 
animals as shown by increases in corticosterone, glucose, growth hormone, heart rate, blood 
pressure, and behavior (Johnson et al. 2000, Balcombe et al. 2004, Hoggatt et al. 2010, 
Hurst and West 2010, Gouveia and Hurst 2013, Vandenberg et al. 2014). Moreover, 
C57BL/6 mice, the strain used in these studies, are one of the more anxiety-prone mouse 
strains (Kim et al. 2002, Michalikova et al. 2010). The body’s response to stress involves the 
sympathetic nervous system and the hypothalamic-pituitary-adrenal axis, resulting in the 
release of stress hormones from the adrenal cortex, including cortisol. After removal of the 
stressor, stress hormones return to basal levels, but if the stressful event continues (such as 
in Admn 3 mice), cortisol may be continually released. It has been shown in humans that 
prolonged exposure to stress hormones can have pathologic outcomes in several systems, 
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including the immune system, thereby increasing morbidity and mortality (McEwen 1998, 
Vogelzangs et al. 2010).
The timing of laboratory manipulations may also play a role in inducing lethal stress when 
one considers that mice are nocturnal animals and frequent disruptions to their normal 
daytime sleep patterns for laboratory procedures may affect immunity (Trammell et al. 
2014). Frequent handling may increase the chances of opportunistic infections, despite 
rigorous practices in the authors’ laboratory to ensure aseptic handling of the mice (cages 
are only opened in biosafety cabinets, gloved hands and cages are sprayed with disinfectant 
before opening/touching the mice, needles are not reused, tails are disinfected before 
snipping, and personnel wear full personal protective gear, including face masks).
CONCLUSIONS
These data illustrate the negative effect that stressful administration schedules of MCM can 
have on survival of lethally-irradiated mice in survival efficacy studies. Mice that underwent 
29 consecutive daily SQ injections of vehicle, or six to nine every other day oral gavages, 
experienced significantly worse survival than mice undergoing one to three SQ or IM 
injections or no injections at all. Survival was most negatively affected by stressful 
administration schedules when higher doses of radiation were used (i.e., LD70/30) 
compared to lower doses (LD30/30). To circumvent the effect that administration schedules 
can have on study outcome, DRR can be constructed using the same administration schedule 
required for the MCM so that LDXX/30 values are reflective of the administration schedule. 
Absent construction of such a DRR, two or more doses of radiation can be selected for the 
efficacy study, taking care to select doses that may be lower than desired. Finally, 
engineering MCM to require fewer injections has the advantages of reducing stress to the 
animals and ease of utility in the field.
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Figure 1. Probit plots
Vehicle-treated control groups from 20 individual survival efficacy studies were divided into 
3 groups based on the severity of the administration (Admn) schedule of their MCM: Admn 
1 (n=5 studies, 274 total mice) underwent no injections, Admn 2 (n=11 studies, 444 total 
mice) underwent 1-3 SQ or IM injections, and Admn 3 (n=4 studies, 199 total mice) 
underwent 29 consecutive daily SQ injections or 6 to 9 every other day oral gavages. Thirty-
day mortality of mice in each group at different radiation doses was used to construct the 
probit plots, with percent mortality on the y-axis and radiation dose on the x-axis. Admn 1 
mice were exposed to only one radiation dose (LD50/30), thus a probit could not be 
constructed. Admn 2 mice were exposed to the LD50/30, LD70/30, LD90/30, and LD95/30. 
Admn 3 mice were exposed to the LD30/30, LD50/30, and LD70/30. All LDXX/30 values 
were derived from the original DRR probit shown on the figure, generated using 164 mice 
randomized into 10 radiation dose groups. The slopes of each probit are given on the figure; 
the slope of Admn 3 was significantly steeper than that of Admn 2 or the original DRR.
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Figure 2. Kaplan-Meier survival curves
A description of the original DRR and Admn groups is given in the legend to Fig. 1. Thirty-
day survival of mice exposed to 8.53 Gy (Admn 1, Admn 2, and Admn 3), or 8.50 Gy 
(original DRR), was used to construct Kaplan-meier survival curves. Survival in Admn 3 
was significantly worse compared to the other groups (p=0.007).
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Table 2
Estimated LDXX/30 values for original DRR, Admn2, and Admn3 groups
Expected LDXX/30 Original DRR Gy (±95% CI) Admn 2 Gy (±95% CI) Admn 3 Gy (±95% CI)
LD30/30 8.34 (0.11) 8.22 (0.13) 8.33 (0.06)
LD50/30 8.53 (0.10) 8.48 (0.07) 8.43 (0.04)
LD70/30 8.72 (0.14) 8.74 (0.08) 8.53 (0.04)
LD90/30 9.04 (0.12) 9.12 (0.25) 8.68 (0.09)
LD95/30 9.22 (0.28) 9.30 (0.34) 8.75 (0.12)
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